Storys zum Thema Pharmakologie

STADA Arzneimittel AG

Press release: STADA welcomes CHMP positive opinion on extending indication for Kinpeygo

STADA welcomes CHMP positive opinion on extending indication for Kinpeygo - The CHMP adopted a positive opinion recommending a change to the terms of the marketing authorization of Kinpeygo for the treatment of adults with primary immunoglobulin A, now covering patients with a UPCR of ≥0.8 g/g - ...

STADA Arzneimittel AG

Press release: Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, in the EU and UK

Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, in the EU and UK - Bio-Thera and STADA have reached an exclusive commercialization and license agreement for BAT2506, a biosimilar candidate to Simponi® ...

ARTTIC Innovation GmbH

canSERV invites applications for "Revolutionising Cancer Patient Care"

ARTTIC Innovation GmbH

3

canSERV invites applications for "Revolutionising Cancer Patient Care"

STADA Arzneimittel AG

Press release: STADA reduces carbon emissions and increases its renewable energy supply on sustainability journey

STADA reduces carbon emissions and increases its renewable energy supply on sustainability journey - Total carbon emissions by STADA reduced by 25% between 2020 and 2023 - Around 45% of STADA’s electricity consumption now comes from renewable ...

STADA Arzneimittel AG

Press release: STADA continues with double-digit sales and profit growth in 2023

STADA Arzneimittel AG

Press release: STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara

STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara - Marketing authorization issued in European Economic Area for Uzpruvo®, the first biosimilar to Stelara®, a biologic therapy within ...

STADA Arzneimittel AG

Press release: Zuellig Pharma becomes STADA Philippines’ exclusive distribution partner

STADA Arzneimittel AG

Press release: STADA strikes partnership with CR Sanjiu in China to drive growth of its cough and cold portfolio

STADA Arzneimittel AG

2

Press release : People with Parkinson’s experience variations in effects of oral medicines, but lack advice, international survey reveals

STADA Arzneimittel AG

2

Press release: STADA's excellent results in H1 2023 indicate a record annual profit of €1 bn, driven by Consumer Healthcare and Specialty

Fördergesellschaft IZB mbH

2

The start-up Eisbach Bio in the IZB near Munich receives 6.7 million euros from the Bavarian state government for the development of a COVID-19 therapeutics

Fördergesellschaft IZB mbH

2

COVID-19: Start-up Eisbach Bio at the IZB receives EUR 8 million government grant

Fördergesellschaft IZB mbH

7

Biotech start-ups at the IZB close deals worth more than 140 million EUR in the first half of 2021

Fördergesellschaft IZB mbH

2

Lindis Biotech develops immunotherapy against bladder cancer

Fördergesellschaft IZB mbH

Origenis founds biotech company Neuron23 in Silicon Valley together with star investor Kleiner Perkins

Fördergesellschaft IZB mbH

3

World Cancer Day: Start-ups at the IZB develop innovative cancer drugs and diagnostic tools

Fördergesellschaft IZB mbH

5

Commemorative publication for the 25th anniversary of the IZB presents 70 profiles and visions of successful biotech start-ups

Fördergesellschaft IZB mbH

KOPIE VON: Inspirational talks form SIRION Biotech, CLS Behring and the German Accelerator at the 13th Biotech Press Lounge at the IZB

Global Health Centre, The Graduate Institute of International and Development Studies

The Lancet and Financial Times partner for first joint Commission on Governing health futures 2030: Growing up in a digital world

Fördergesellschaft IZB mbH

The development of a combination drug for immunotherapy and trends of the VC and pharmaceutical branch were introduced at the IZB